Hawaii Medical Service Association (HMSA) policy updates
Track new and updated Hawaii Medical Service Association (HMSA) policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Denosumab Products for Osteoporosis and Cancer-Treatment-Related Bone Loss | Hawaii Medical Service Association (HMSA) | Clinical | Pharmacy & Specialty Drugs | Modified | Oct 1, 2026 |
| Prolia (denosumab) and Denosumab Biosimilars | Hawaii Medical Service Association (HMSA) | Clinical | Pharmacy & Specialty Drugs | Modified | Oct 1, 2026 |
| Pharmacy Global Oncology | Hawaii Medical Service Association (HMSA) | Clinical | Pharmacy & Specialty Drugs | Modified | Jul 23, 2026 |
| Dupixent (dupilumab) Coverage and Prior Authorization | Hawaii Medical Service Association (HMSA) | Clinical | Pharmacy & Specialty Drugs | Modified | Jul 1, 2026 |
| Dupixent (dupilumab) Coverage and Prior Authorization | Hawaii Medical Service Association (HMSA) | Clinical | Pharmacy & Specialty Drugs | Modified | Jul 1, 2026 |
| Nemluvio (nemolizumab-ilto) Coverage Criteria | Hawaii Medical Service Association (HMSA) | Clinical | Pharmacy & Specialty Drugs | Modified | Jul 1, 2026 |
| Adbry (tralokinumab-ldrm) Coverage Criteria | Hawaii Medical Service Association (HMSA) | Clinical | Pharmacy & Specialty Drugs | Modified | Jul 1, 2026 |
| Cibinqo (abrocitinib) Coverage Criteria for Atopic Dermatitis | Hawaii Medical Service Association (HMSA) | Clinical | Pharmacy & Specialty Drugs | Modified | Jul 1, 2026 |
| Ebglyss (lebrikizumab-lbkz) Coverage for Moderate-to-Severe Atopic Dermatitis | Hawaii Medical Service Association (HMSA) | Clinical | Pharmacy & Specialty Drugs | Modified | Jul 1, 2026 |
| Gazyva (obinutuzumab) Coverage for Active Lupus Nephritis | Hawaii Medical Service Association (HMSA) | Clinical | Pharmacy & Specialty Drugs | Modified | Jul 1, 2026 |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.